GlassScriptPhysician profile
Bridget Mckinley
NPI 1720427115
$6,322.62
in general payments reported to CMS, 2019-2025
32 companies · $1,396 in 2025
The $1,396 reported for 2025 was more than what 91% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $662 · 2022: $1,062 · 2023: $1,585 · 2024: $1,618 · 2025: $1,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,598.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $789.47 | 2022-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $746.39 | 2021-2025 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals LP | $710.49 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $558.09 | 2021-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $464.20 | 2021-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $395.05 | 2021-2025 | Uptravi, Opsumit |
| Takeda Pharmaceuticals U.S.A., INC. | $374.72 | 2021-2025 | Aralast, Glassia |
| Genzyme Corporation | $366.47 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $313.57 | 2022-2025 | Dupixent |
| United Therapeutics Corporation | $290.61 | 2021-2025 | Tyvaso, Tyvaso, Orenitram |
| Amgen INC. | $247.20 | 2023-2025 | Tezspire, Tavneos |
| Mylan Specialty L.P. | $102.09 | 2021-2024 | Yupelri |
| Astellas Pharma US INC | $90.54 | 2021-2024 | Cresemba |
| Merck Sharp & Dohme LLC | $83.34 | 2023-2025 | Zerbaxa, Recarbrio, Dificid |
| Baxter Healthcare | $79.46 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $78.35 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth, Inogen At Home Stationary Concentrator, Inogen One G3 Oxygen Concentrator |
| Bayer Healthcare Pharmaceuticals INC. | $76.38 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $68.25 | 2021-2022 | |
| Csl Behring | $59.01 | 2021-2023 | Kcentra |
| Mayne Pharma Commercial LLC | $58.16 | 2021-2022 | |
| Pulmonx Corporation | $56.49 | 2022-2023 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Philips North America LLC | $52.59 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Viatris Specialty LLC | $50.63 | 2025 | Yupelri |
| Verona Pharma, INC. | $45.35 | 2025 | Ohtuvayre |
| Boston Scientific Corporation | $32.74 | 2024 | Ekosonic |
| Electromed, INC. | $29.59 | 2023-2024 | Smartvest |
| Paratek Pharmaceuticals, INC. | $19.34 | 2025 | Nuzyra |
| Genentech USA, INC. | $19.27 | 2021 | |
| Mallinckrodt Hospital Products INC. | $17.59 | 2021 | |
| Sandoz INC. | $17.20 | 2023 | Treprostinil |
| Sunovion Pharmaceuticals INC. | $16.62 | 2021 | |
| Abbvie INC. | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Mckinley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.